NAIMES/32 – A randomized double-blind, placebo controlled study to assess the safety and the efficacy of Neridronate ampoules 25 mg, after repeated intramuscular administration, in patients with complex Regional Pain Syndrome type 1 (CRPS-1)

1. Home
2. Ricerca
3. Progetti
4. NAIMES/32 – A randomized double-blind, placebo controlled study to assess the safety and the efficacy of Neridronate ampoules 25 mg, after repeated intramuscular administration, in patients with complex Regional Pain Syndrome type 1 (CRPS-1)